The pet industry is expected to witness significant growth, driven by the surging demand for pet products and healthcare ...

Zoetis (NYSE:ZTS – Get Free Report) is expected to issue its quarterly earnings data before the market opens on Thursday, ...

PARSIPPANY, N.J. - Zoetis Inc . (NYSE:ZTS), a global leader in animal health, has announced a quarterly dividend of $0.50 per share for the second quarter of 2025. The declared dividend is payable on ...

Zoetis Inc. today announced that it has updated the U.S. label for Librela® (bedinvetmab injection), following its submission of a supplement to the U.S. Food and Drug Administration (FDA). This ...

Mutual Advisors LLC increased its position in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 31.4% during the fourth ...

The overall opportunity in the US market is significant, with an estimated 28% of dogs experiencing ... based Zoetis, Inc. is the world’s largest manufacturer of medicine and vaccinations ...

The pharmaceutical company that developed and sells Librela is Zoetis ... for your dog, like an injection for diabetics that is now labeled as a weight control medication, or a new vaccine ...

Hunter, Trooper, Scrappy and Buckaroo find zen by using Zenrelia <li /> Newly published study in a leading peer-reviewed, ...

Newly published study in a leading peer-reviewed, international journal, Veterinary Dermatology, compares clinical outcomes between Zenrelia and Apoquel® (oclacitinib tablet) ...